ArticleJournal of translational medicine2025

Multimodal prediction of tyrosine kinase inhibitors therapy outcomes in advanced EGFR-mutated NSCLC patients.

Xiaodong Chai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.